Mologen AG
🏢 View company profile →14Patents
11Active
14Granted
43Portfolio score
Filing activity: Aug 27, 2002 → Jun 26, 2019 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9499815B1 | Multimer for immunostimulation | Chemistry; Metallurgy | 11 | Active |
| US9212366B2 | Immune modulating oligonucleotides in connection with chemotherapeutic measures | Chemistry; Metallurgy | 9 | Active |
| US7635468B2 | Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine | Chemistry; Metallurgy | 8 | Active |
| US10487333B2 | Combination comprising immunostimulatory oligonucleotides | Chemistry; Metallurgy | 7 | Active |
| US10280424B2 | Covalently closed non-coding immunomodulatory DNA construct | Chemistry; Metallurgy | 5 | Active |
| US10006032B2 | Predictive biomarker for cancer therapy | Physics | 4 | Active |
| US7074772B2 | Design principle for the construction of expression constructs for gene therapy | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10604760B2 | Combination comprising immunostimulatory oligonucleotides | Chemistry; Metallurgy | 4 | Active |
| US9345754B2 | Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine | Chemistry; Metallurgy | 2 | Active |
| US9375435B2 | Use of a DNA expression construct | Chemistry; Metallurgy | 2 | Active |
| US7915035B2 | Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat | Chemistry; Metallurgy | 1 | Expired |
| US7795406B2 | Agent for treating leishmania infections | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8669100B2 | DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US9012620B2 | DNA constructs for specific inhibition of gene expression by RNA interference | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.